A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF)
Clinical trial NCT05668741 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05668741
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-27
- Primary completion
- 2026-04-21
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.